Non-clinical safety assessment of covalent BI-TOX to support neuropathic pain indication
Ended Awarded Last action
- Contract number
- 75N95022F00001
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $765,995
Award facts
- Opportunity
-
- 75N95022R00078 Solicitation number
- Contract value 31% obligated
-
- $765,995.00 Current, with exercised options
- $2,495,455.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $22,262 | |
| Original award | $743,733 |
About this award
This is a $2,495,455.00 delivery order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of Technology. The contract is for non-clinical safety assessment of a covalent bi-tox compound to support a neuropathic pain indication. This delivery order is part of a larger $48.6 million multiple-award CRO Support for NCATS In Vitro and In Vivo Toxicology Studies indefinite delivery/indefinite quantity (IDIQ) contract vehicle. IITRI has extensive experience providing preclinical research services, including toxicology studies, to federal agencies like NCATS. No set-aside designation was used for this award.
Quick answers
Who was awarded contract 75N95022F00001?
75N95022F00001 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2022.
How much is contract 75N95022F00001 worth?
The government has obligated $765,995 on 75N95022F00001. Its potential value, with all options, is $2,495,455.
Which agency awarded contract 75N95022F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95022F00001 an order under another contract?
Yes. 75N95022F00001 is a delivery order under HHSN271201700016I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95022F00001 competed?
The extent of competition for 75N95022F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award